<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: successfully", fill: "#e4717a"},
{source: "2: successfully", target: "2: strategic initiatives", fill: "#e4717a"},
{source: "2: strategic initiatives", target: "2: organizational", fill: "#e4717a"},
{source: "2: organizational", target: "2: future productivity", fill: "#e4717a"},
{source: "2: future productivity", target: "2: profitability", fill: "#e4717a"},
{source: "2: profitability", target: "2: adversely affected", fill: "#e4717a"},
{source: "2: successfully", target: "6: successfully", fill: "#872657"},
{source: "6: successfully", target: "6: significant", fill: "#872657"},
{source: "6: significant", target: "6: operations", fill: "#872657"},
{source: "6: operations", target: "6: future profitability", fill: "#872657"},
{source: "6: successfully", target: "14: new prescription drug", fill: "#c50"},
{source: "14: new prescription drug", target: "14: profitability", fill: "#c50"},
{source: "14: profitability", target: "14: adversely affected", fill: "#c50"},
{source: "14: new prescription drug", target: "15: Effective January ", fill: "#343434"},
{source: "15: Effective January ", target: "15: pharmacy benefit services subsidiary", fill: "#343434"},
{source: "15: pharmacy benefit services subsidiary", target: "15: began offering three prescription drug", fill: "#343434"},
{source: "15: began offering three prescription drug", target: "15: provide prescription", fill: "#343434"},
{source: "15: provide prescription", target: "15: Medicare Prescription Drug Improvement ", fill: "#343434"},
{source: "15: Effective January ", target: "17: prescription", fill: "#ff43a4"},
{source: "17: prescription", target: "17: profitability", fill: "#ff43a4"},
{source: "17: profitability", target: "17: adversely", fill: "#ff43a4"},
{source: "17: prescription", target: "19: legislative", fill: "#69c"},
{source: "19: legislative", target: "19: regulatory", fill: "#69c"},
{source: "19: regulatory", target: "19: competitive", fill: "#69c"},
{source: "19: competitive", target: "19: conditions", fill: "#69c"},
{source: "19: conditions", target: "19: prescription", fill: "#69c"},
{source: "19: prescription", target: "19: generate profitable prescription drug", fill: "#69c"},
{source: "19: legislative", target: "START_HERE", fill: "#69c"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Construction and Engineering</td>
    </tr>
    <tr>
      <td>Construction Materials</td>
    </tr>
    <tr>
      <td>Construction and Farm Machinery and Heavy Trucks</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Insurance Brokers</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Pharmaceuticals Biotechnology and Life Sciences</td>
    </tr>
    <tr>
      <td>Pharmaceuticals</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Material Aid</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profit_(economics)">Profit (economics)</a></td>
      <td>An economic profit is the difference between the revenue a  commercial entity has received from its outputs and the opportunity costs of its inputs. It equals to total revenue minus total cost, including both explicit and implicit costs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_index">Profitability index</a></td>
      <td>Profitability index (PI), also known as profit investment ratio (PIR) and value investment ratio (VIR), is the ratio of payoff to investment of a proposed project. It is a useful tool for ranking projects because it allows you to quantify the amount of value created per unit of investment.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_Profitability_Analysis">Customer Profitability Analysis</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_Is_Profitable">Small Is Profitable</a></td>
      <td>Small Is Profitable: The Hidden Economic Benefits of Making Electrical Resources the Right Size is a 2002 book by energy analyst Amory Lovins and others.  The book describes 207 ways in which the size of "electrical resources"—devices that make, save, or store electricity—affects their economic value.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitable_growth">Profitable growth</a></td>
      <td>Profitable Growth is the combination of profitability and growth, more precisely the combination of Economic Profitability and Growth of Free cash flows. Profitable growth is aimed at seducing the financial community; it emerged in the early 80s when shareholder value creation became firms’ main objective.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_profitability">Customer profitability</a></td>
      <td>Customer profitability (CP) is the profit the firm makes from serving a customer or customer group over a specified period of time, specifically the difference between the revenues earned from and the costs associated with the customer relationship in a specified period. According to Philip Kotler,"a profitable customer is a person, household or a company that overtime, yields a revenue stream that exceeds by an acceptable amount the company's cost stream of attracting, selling and servicing the customer."\nCalculating customer profit is an important step in understanding which customer relationships are better than others.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/SAP_ERP">SAP ERP</a></td>
      <td>SAP ERP is an enterprise resource planning software developed by the German company SAP SE. SAP ERP incorporates the key business functions of an organization. The latest version of SAP ERP (V.6.0) was made available in 2006.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Porter's_five_forces_analysis">Porter's five forces analysis</a></td>
      <td>Porter's Five Forces Framework is a method of analysing the operating environment of a competition of a business. It draws from industrial organization (IO) economics to derive five forces that determine the competitive intensity and, therefore, the attractiveness (or lack thereof) of an industry in terms of its profitability.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Return_on_equity">Return on equity</a></td>
      <td>The return on equity (ROE) is a measure of the profitability of a business in relation to the equity. Because shareholder's equity can be calculated by taking all assets and subtracting all liabilities, ROE can also be thought of as a return on assets minus liabilities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Assets_under_management">Assets under management</a></td>
      <td>In finance, assets under management (AUM), sometimes called funds under management, measures the total market value of all the financial assets which an individual or financial institution—such as a mutual fund, venture capital firm, or depository institution—or a decentralized network protocol controls, typically on behalf of a client.  These funds may be managed for clients/users or for themselves in the case of a financial institution which has mutual funds or holds its own venture capital.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Life_Insurance_Corporation">Life Insurance Corporation</a></td>
      <td>Life Insurance Corporation of India (LIC) is an Indian statutory insurance and investment corporation headquartered in the city of Mumbai, India. It is under the ownership of Government of India.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ivor_Montagu">Ivor Montagu</a></td>
      <td>Ivor Goldsmid Samuel Montagu (23 April 1904, in Kensington, London – 5 November 1984, in Watford) was an English filmmaker, screenwriter, producer, film critic, writer, table tennis player, and Communist activist in the 1930s. He helped to develop a lively intellectual film culture in Britain during the interwar years, and was also the founder of the International Table Tennis Federation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Defence_mechanism">Defence mechanism</a></td>
      <td>In psychoanalytic theory, a defence mechanism (American English: defense mechanism), is an unconscious psychological operation that functions to protect a person from anxiety-producing thoughts and feelings related to internal conflicts and outer stressors.Defence mechanisms may result in healthy or unhealthy consequences depending on the circumstances and frequency with which the mechanism is used. Defence mechanisms (German: Abwehrmechanismen) are psychological strategies brought into play by the unconscious mind to manipulate, deny, or distort reality in order to defend against feelings of anxiety and unacceptable impulses and to maintain one's self-schema or other schemas.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Day_the_Music_Died">The Day the Music Died</a></td>
      <td>On February 3, 1959, American rock and roll musicians Buddy Holly, Ritchie Valens, and "The Big Bopper" J. P. Richardson were killed in a plane crash near Clear Lake, Iowa, together with pilot Roger Peterson. The event later became known as "The Day the Music Died" after singer-songwriter Don McLean referred to it as such in his 1971 song "American Pie".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Botswana">Botswana</a></td>
      <td>Botswana ( (listen), also UK: ), officially the Republic of Botswana (Setswana: Lefatshe la Botswana, [lɪˈfatsʰɪ la bʊˈtswana]), is a landlocked country in Southern Africa. Botswana is topographically flat, with up to 70 percent of its territory being the Kalahari Desert.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_other">Significant other</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_form">Significant form</a></td>
      <td>Significant form refers to an aesthetic theory developed by English art critic Clive Bell which specified a set of criteria for what qualified as a work of art.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Others">Significant Others</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Statistical_significance">Statistical significance</a></td>
      <td>In statistical hypothesis testing, a result has statistical significance when it is very unlikely to have occurred given the null hypothesis. More precisely, a study's defined significance level, denoted by \n  \n    \n      \n        α\n      \n    \n    {\displaystyle \alpha }\n  , is the probability of the study rejecting the null hypothesis, given that the null hypothesis is true; and the p-value of a result, \n  \n    \n      \n        p\n      \n    \n    {\displaystyle p}\n  , is the probability of obtaining a result at least as extreme, given that the null hypothesis is true.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Simpsons">The Simpsons</a></td>
      <td>The Simpsons is an American animated sitcom created by Matt Groening for the Fox Broadcasting Company. The series is a satirical depiction of American life, epitomized by the Simpson family, which consists of Homer, Marge, Bart, Lisa, and Maggie.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Mother">Significant Mother</a></td>
      <td>Significant Mother is an American television sitcom created by Erin Cardillo and Richard Keith. Starring Josh Zuckerman, Nathaniel Buzolic and Krista Allen, it premiered on The CW network on August 3 and ended its run on October 5, 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Internet">Internet</a></td>
      <td>In finance and economics, interest is payment from a borrower or deposit-taking financial institution to a lender or depositor of an amount above repayment of the principal sum (that is, the amount borrowed), at a particular rate. It is distinct from a fee which the borrower may pay the lender or some third party.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Over-the-counter_drug">Over-the-counter drug</a></td>
      <td>Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription.  In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Eyeglass_prescription">Eyeglass prescription</a></td>
      <td>An eyeglass prescription is an order written by an eyewear prescriber, such as an optometrist, that specifies the value of all parameters the prescriber has deemed necessary to construct and/or dispense corrective lenses appropriate for a patient. If an eye examination indicates that corrective lenses are appropriate, the prescriber generally provides the patient with an eyewear prescription at the conclusion of the exam.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Prescription_for_Death">Prescription for Death</a></td>
      <td>"Prescription for Death" is the first episode of the long-running crime drama television series Law &amp; Order. It aired on September 13, 1990.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Linguistic_prescription">Linguistic prescription</a></td>
      <td>Linguistic prescription, or prescriptive grammar, is the establishment of rules defining preferred  usage of language. These rules may address such linguistic aspects as spelling, pronunciation, vocabulary, syntax, and semantics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Yoda_conditions">Yoda conditions</a></td>
      <td>In programming jargon, Yoda conditions (also called Yoda notation) is a programming style where the two parts of an expression are reversed from the typical order in a conditional statement. A Yoda condition places the constant portion of the expression on the left side of the conditional statement.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dirichlet_conditions">Dirichlet conditions</a></td>
      <td>In mathematics, the Dirichlet conditions are sufficient conditions for a real-valued, periodic function f to be equal to the sum of its Fourier series at each point where f is continuous. Moreover, the behavior of the Fourier series at points of discontinuity is determined as well (it is the midpoint of the values of the discontinuity).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Twenty-one_Conditions">Twenty-one Conditions</a></td>
      <td>The Twenty-one Conditions, officially the Conditions of Admission to the Communist International, refer to the conditions, most of which were suggested by Vladimir Lenin, to the adhesion of the socialist parties to the Third International (Comintern) created in 1919. The conditions were formally adopted by the Second Congress of the Comintern in 1920.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Nervous_Conditions">Nervous Conditions</a></td>
      <td>Nervous Conditions is a novel by Zimbabwean author Tsitsi Dangarembga, first published in the United Kingdom in 1988. It was the first book published by a black woman from Zimbabwe in English.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Conditions_races">Conditions races</a></td>
      <td>Conditions races are horse races in which the weights carried by the runners are laid down by the conditions attached to the race. Weights are allocated according to the sex of the runners, with female runners carrying less weight than males; the age of the runners, with younger horses receiving weight from older runners to allow for relative maturity, referred to as weight for age; and the quality of the runners, with horses that have won certain values of races giving weight to less successful entrants.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Conditions_of_Learning">Conditions of Learning</a></td>
      <td>Conditions of Learning, by Robert M. Gagné, was originally published in 1965 by Holt, Rinehart and Winston and describes eight kinds of learning and nine events of instruction. This theory of learning involved two steps.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Conditions_(album)">Conditions (album)</a></td>
      <td>Conditions is the debut studio album by Australian rock band The Temper Trap, released in Australia through Liberation Music on 19 June 2009. It was later released in the United Kingdom on 10 August 2009.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>LONGS DRUG STORES CORP      Item 1A Risk Factors          You <font color="blue">should carefully</font> read the <font color="blue">following risk factors</font></td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">successfully</font> execute our <font color="blue">strategic <font color="blue">initiatives</font></font> and the     related <font color="blue"><font color="blue">organization</font>al</font> changes, our <font color="blue">future productivity</font> and <font color="blue">profitability</font>     may be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>We are currently undertaking a series of <font color="blue">strategic <font color="blue">initiatives</font></font> designed to     make  Longs  a  stronger <font color="blue">competitor</font> and more profitable company</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue"><font color="blue">initiatives</font> address several core elements</font> of our <font color="blue">operations</font>, including our     supply chain, front-end sales, pharmacy <font color="blue">profitability</font>, customer service and     <font color="blue">operational processes</font>, and involve <font color="blue">significant</font> <font color="blue"><font color="blue">organization</font>al</font> change</td>
    </tr>
    <tr>
      <td><font color="blue">Such     </font><font color="blue"><font color="blue">organization</font>al</font> changes are complex and could cause <font color="blue"><font color="blue">disruption</font>s</font> that would     <font color="blue"><font color="blue">adversely</font> affect</font> our revenues and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Our ability to <font color="blue">successfully</font>     implement  these  changes, which are <font color="blue">significant</font> to our <font color="blue">operations</font> and     business, is critical to our future <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>If we are not successful,     we may not achieve the expected <font color="blue">benefits from</font> these <font color="blue">initiatives</font>, despite     having expended <font color="blue">significant</font> capital and <font color="blue">human effort</font></td>
    </tr>
    <tr>
      <td>Furthermore, we may     encounter  <font color="blue"><font color="blue">difficult</font>ies</font>  <font color="blue">implementing</font>  this  amount  of  change in our     <font color="blue">organization</font> that could have a <font color="blue">negative impact on</font> our <font color="blue">implementation</font> plans     and project budgets</td>
    </tr>
    <tr>
      <td>If the <font color="blue">construction</font> of and transition to our new front-end <font color="blue">distribution</font>     center is not successful, our <font color="blue"><font color="blue"><font color="blue">retail drug</font> store</font> sales</font> and <font color="blue">profitability</font>     could be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">currently constructing</font> an 800cmam000 square foot <font color="blue">distribution</font> <font color="blue">facility</font>     for front-end merchandise in Patterson, California, scheduled for <font color="blue">completion</font>     in the summer of fiscal 2007</td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">successfully</font> complete     <font color="blue">construction</font> of this <font color="blue">facility</font> on a <font color="blue">timely basis</font>, to transition hundreds of     front-end  vendors  to  <font color="blue">direct supplier relationships</font>, or <font color="blue">successfully</font>     implement the <font color="blue"><font color="blue">necessary</font> systems</font> and process changes <font color="blue">associated with</font> the     transition  to  the  new  <font color="blue">facility</font>,  our <font color="blue">supply chain could</font> experience     <font color="blue">significant</font> <font color="blue"><font color="blue">disruption</font>s</font></td>
    </tr>
    <tr>
      <td>Such <font color="blue"><font color="blue">disruption</font>s</font> could <font color="blue"><font color="blue">adversely</font> affect</font> our retail     drug  store  sales  and  increase  our cost of sales and operating and     <font color="blue">administrative expenses</font></td>
    </tr>
    <tr>
      <td>We may also determine that <font color="blue">additional investment</font> of     time or money is required to <font color="blue">successfully</font> complete the transition to this     new <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">new <font color="blue">prescription</font> drug</font> plans do not generate the anticipated revenues     or <font color="blue">profitability</font>, our financial results could be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td><font color="blue">Effective January </font>1, 2006, through our <font color="blue">pharmacy benefit services subsidiary</font>,     we <font color="blue">began offering three <font color="blue">prescription</font> drug</font> plans that <font color="blue">provide <font color="blue">prescription</font></font>     drug  benefits  under  the Medicare Prescription Drug, Improvement and     Modernization  Act of 2003</td>
    </tr>
    <tr>
      <td>Because this is a new federally subsidized     benefit and we have not <font color="blue">previously offered such</font> plans, it is <font color="blue">difficult</font> to     predict the revenues and <font color="blue">profitability</font> of this new business</td>
    </tr>
    <tr>
      <td>If the revenues     we generate from providing these benefits are not sufficient to cover the     related  <font color="blue">prescription</font>  drug costs, our <font color="blue">profitability</font> will be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>Furthermore,  these plans are subject to <font color="blue">annual bidding</font> and     <font color="blue"><font color="blue">regulatory</font> approval</font></td>
    </tr>
    <tr>
      <td>Changes in <font color="blue">legislative</font>, <font color="blue">regulatory</font> or <font color="blue">competitive</font>     <font color="blue">conditions</font> could affect our ability to continue to offer <font color="blue">prescription</font> drug     plans or to generate profitable <font color="blue">prescription</font> drug plan revenues</td>
    </tr>
    <tr>
      <td><font color="blue">Changes  </font>in economic <font color="blue">conditions</font> could <font color="blue"><font color="blue">adversely</font> affect</font> consumer buying     practices and reduce our revenues and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Our performance is affected by economic <font color="blue">conditions</font> such as overall economic     growth and unemployment, especially in California, our <font color="blue">primary market</font></td>
    </tr>
    <tr>
      <td>Higher  <font color="blue">gasoline prices</font> have also had a <font color="blue">significant</font> impact on consumer     spending in our markets</td>
    </tr>
    <tr>
      <td><font color="blue">Deterioration </font>in economic <font color="blue">conditions</font>, <font color="blue">particularly</font>     in California, could <font color="blue"><font color="blue">adversely</font> affect</font> our revenues and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>For     example, an increase in <font color="blue">unemployment could</font> cause consumers to lose their     health insurance, <font color="blue">which could</font> in turn <font color="blue"><font color="blue">adversely</font> affect</font> our <font color="blue">pharmacy sales</font></td>
    </tr>
    <tr>
      <td>Further, a decrease in overall consumer spending as a result of changes in     economic <font color="blue">conditions</font> could <font color="blue"><font color="blue">adversely</font> affect</font> our front-end sales</td>
    </tr>
    <tr>
      <td>Our profit     margins  are <font color="blue">higher on</font> our front-end sales than our <font color="blue">pharmacy sales</font> and     therefore any decrease in our sales of front-end products would have a     disproportionate <font color="blue">negative impact on</font> our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>6     ______________________________________________________________________    [33]Table of <font color="blue">Contents       </font>The <font color="blue"><font color="blue">retail drug</font> store</font> and <font color="blue">pharmacy benefit services industries</font> are highly     <font color="blue">competitive</font> and <font color="blue">further increases</font> in competition could <font color="blue"><font color="blue">adversely</font> affect</font> us</td>
    </tr>
    <tr>
      <td>We face intense competition with local, regional and <font color="blue">national companies</font>,     including  other  drug  store chains, in<font color="blue">dependent</font> drug stores, on-line     retailers, supermarket chains and <font color="blue">mass merchandisers</font>, many of whom are     <font color="blue">aggressively expanding</font> in markets we serve</td>
    </tr>
    <tr>
      <td>In addition, competition from     mail order pharmacies is <font color="blue">rapidly intensifying</font>, and some third-party health     plans require mail-order fulfillment of <font color="blue">certain medications</font></td>
    </tr>
    <tr>
      <td>In the pharmacy     benefit  services industry, our <font color="blue">competitor</font>s include large national and     regional pharmacy benefit managers and insurance companies and managed care     providers, some of which are owned by or have <font color="blue">affiliations</font> with our retail     drug store <font color="blue">competitor</font>s</td>
    </tr>
    <tr>
      <td>Many of our <font color="blue">competitor</font>s have <font color="blue">substantially</font> greater     resources, including name <font color="blue">recognition</font> and capital resources, than we do</td>
    </tr>
    <tr>
      <td>As     <font color="blue">competition increases</font> in the markets in which we operate, a <font color="blue">significant</font>     increase in <font color="blue">general pricing pressures could</font> occur, <font color="blue">which could</font> require us to     reduce prices, purchase more <font color="blue">effectively</font> and <font color="blue">increase customer service</font> to     remain <font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>We may not be able to continue to compete <font color="blue">effectively</font> in     our markets or increase our revenues or margins in response to further     <font color="blue">increased competition</font></td>
    </tr>
    <tr>
      <td><font color="blue">Reductions </font>in third-party, including <font color="blue">government</font>, <font color="blue">reimbursement</font> levels for     <font color="blue">prescription</font> drugs continue to reduce our margins on <font color="blue">pharmacy sales</font> and     could have a <font color="blue">significant</font> effect on our <font color="blue"><font color="blue"><font color="blue">retail drug</font> store</font> sales</font> and gross     profits</td>
    </tr>
    <tr>
      <td>Third-party health plans cover more than 90prca of all the <font color="blue">prescription</font> drugs     that we sell</td>
    </tr>
    <tr>
      <td>Pharmacy <font color="blue">sales covered by third parties</font> have lower gross     margins than non third-party <font color="blue">pharmacy sales</font>, and third-party health plans     continue  to  reduce  the  levels  at  which they <font color="blue">reimburse us</font> for the     <font color="blue">prescription</font>  drugs  that  we  provide  to their members</td>
    </tr>
    <tr>
      <td>Furthermore,     <font color="blue">government</font>-sponsored health plans such as <font color="blue">Medicare and Medicaid </font>are making     continuing  efforts to reduce their costs, including <font color="blue">prescription</font> drug     <font color="blue">reimbursement</font>s, and the new Medicare <font color="blue">prescription</font> drug benefit resulted in     lower <font color="blue">reimbursement</font> levels for <font color="blue">prescription</font> drugs provided to <font color="blue">Medicare     </font><font color="blue">participants</font></td>
    </tr>
    <tr>
      <td>If third-party health plans, including <font color="blue">government</font>-sponsored     plans, continue to reduce their <font color="blue">reimbursement</font> levels, our <font color="blue"><font color="blue">retail drug</font> store</font>     sales and gross <font color="blue">profits could</font> be <font color="blue">significant</font>ly <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">significant</font> <font color="blue">investments</font> we are making in our stores may not increase our     <font color="blue"><font color="blue"><font color="blue">retail drug</font> store</font> sales</font> and <font color="blue">profitability</font>, <font color="blue">which could</font> <font color="blue"><font color="blue">adversely</font> affect</font> our     results of <font color="blue">operations</font>, <font color="blue">financial condition</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>We have recently made and are continuing to make <font color="blue">significant</font> <font color="blue">investments</font> in     our <font color="blue"><font color="blue">retail drug</font> store</font>s in an effort to increase our sales and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">investments</font> include the <font color="blue">installation</font> of <font color="blue">new digital photo equipment</font>,     pharmacy and other <font color="blue">technology</font>, and remodels and other <font color="blue">improvements</font> to some     <font color="blue">existing stores</font></td>
    </tr>
    <tr>
      <td>We also plan to <font color="blue">significant</font>ly increase the rate of new     <font color="blue">store openings</font> in fiscal 2007</td>
    </tr>
    <tr>
      <td>Some of these <font color="blue">investments</font> require <font color="blue">significant</font>     capital <font color="blue">expenditures</font> and <font color="blue">human effort</font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">uncertain about consumer</font>     reaction to these changes and therefore these <font color="blue">investments</font> may not result in     <font color="blue">increased sales</font> and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>A failure to increase our <font color="blue">retail drug</font>     store  sales  and  <font color="blue">profitability</font> would <font color="blue"><font color="blue">adversely</font> affect</font> our results of     <font color="blue">operations</font>, <font color="blue">financial condition</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>If  our  insurance-related costs increase <font color="blue">significant</font>ly, our financial     position and results of <font color="blue">operations</font> could be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>The  costs  of  many types of insurance and self-insurance, especially     workers’ compensation, employee health care and others have <font color="blue">been highly</font>     volatile in <font color="blue">recent years</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">conditions</font> have <font color="blue">been exacerbated by rising</font>     health care costs, <font color="blue">legislative</font> changes, economic <font color="blue">conditions</font>, terrorism and     <font color="blue">heightened scrutiny</font> of <font color="blue">insurance brokers</font> and <font color="blue">insurance providers</font></td>
    </tr>
    <tr>
      <td>If our     insurance-related costs increase <font color="blue">significant</font>ly, our <font color="blue">financial position</font> and     results of <font color="blue">operations</font> could be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>We  are <font color="blue">substantially</font> <font color="blue">dependent</font> on a <font color="blue">single supplier</font> of <font color="blue">pharmaceutical</font>     products to <font color="blue">sell products</font> to us on satisfactory terms</td>
    </tr>
    <tr>
      <td>A <font color="blue">disruption</font> in our     <font color="blue">relationship with</font> this <font color="blue">supplier could</font> have a material adverse effect on our     business</td>
    </tr>
    <tr>
      <td>We  purchase  over  90prca of our <font color="blue">pharmaceutical</font>s from a <font color="blue">single supplier</font>,     AmerisourceBergen,  with whom we have a long-term supply contract</td>
    </tr>
    <tr>
      <td>Any     <font color="blue">significant</font> <font color="blue"><font color="blue">disruption</font>s</font> in our <font color="blue">relationship with</font> AmerisourceBergen,                                           7     ______________________________________________________________________    [34]Table of <font color="blue">Contents       </font><font color="blue">deterioration</font> in AmerisourceBergen’s <font color="blue">financial condition</font>, or industry-wide     changes   in   wholesaler   business  practices,  including  those  of     AmerisourceBergen, could have a material adverse effect on us</td>
    </tr>
    <tr>
      <td>Our ability to attract and retain <font color="blue">pharmacy personnel</font> and develop alternate     <font color="blue">fill sources</font> is important to the <font color="blue">continued success</font> of our business</td>
    </tr>
    <tr>
      <td>The <font color="blue"><font color="blue">retail drug</font> store</font> industry is continuing to experience a shortage of     <font color="blue">licensed <font color="blue">pharmacists</font></font> in the markets in which we operate</td>
    </tr>
    <tr>
      <td>If we are unable to     attract and retain <font color="blue">pharmacists</font>, our business could be <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>In     order to mitigate this risk we have established centralized <font color="blue">prescription</font>     <font color="blue">fill centers</font> and have also installed robotic <font color="blue">prescription</font> fill equipment in     many of our pharmacies</td>
    </tr>
    <tr>
      <td>The success of these efforts, which at this time is     uncertain,  is  important  to  our  ability to address the shortage of     <font color="blue">pharmacists</font>,  but  <font color="blue">additional efforts may</font> be <font color="blue">necessary</font> to address this     business issue</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font><font color="blue">investment may</font> be costly, and could <font color="blue">adversely</font>     affect our results of <font color="blue">operations</font>, <font color="blue">financial condition</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>We are subject to <font color="blue">government</font>al <font color="blue">regulations</font>, procedures and <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">noncompliance with</font>, or a <font color="blue">significant</font> change in, these <font color="blue"><font color="blue">regulations</font> could</font> have     a material adverse effect on us</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">retail drug</font> store</font> and <font color="blue">pharmacy benefit services businesses</font> are subject     to <font color="blue">numerous federal</font>, state and <font color="blue">local <font color="blue">regulations</font></font>, many of which are new and     developing</td>
    </tr>
    <tr>
      <td>These include, but are not limited to, <font color="blue">local registrations</font> and     regulation of pharmacies in the states where our pharmacies are located or     licensed and applicable <font color="blue">Medicare and Medicaid </font><font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>In addition, the     Health Insurance Portability and Accountability Act, or HIPAA, imposes     certain  <font color="blue">requirements</font> regarding the protection of <font color="blue">confidential patient</font>     <font color="blue">medical records</font> and other information</td>
    </tr>
    <tr>
      <td><font color="blue">Compliance </font>with these <font color="blue">regulations</font>,     <font color="blue">particularly</font>  HIPAA, requires that we implement complex changes to our     systems and processes</td>
    </tr>
    <tr>
      <td>In the future we may also be subject to various state     insurance laws and <font color="blue">regulations</font> in <font color="blue">connection</font> with our <font color="blue">prescription</font> drug plan     business</td>
    </tr>
    <tr>
      <td>Failure to adhere to these and other applicable <font color="blue"><font color="blue">regulations</font> could</font>     result in the imposition of civil and <font color="blue">criminal penalties</font></td>
    </tr>
    <tr>
      <td>Furthermore, any     new federal or state <font color="blue">regulations</font> or reforms, including healthcare reform     <font color="blue">initiatives</font> or pharmacy benefit <font color="blue">management</font> regulation, could <font color="blue">adversely</font>     affect us</td>
    </tr>
    <tr>
      <td>Should  a product <font color="blue">liability</font> issue arise, inadequate insurance coverage     against such risks or <font color="blue">inability</font> to maintain such insurance may result in a     material adverse effect on our business</td>
    </tr>
    <tr>
      <td><font color="blue">Pharmacies </font>are exposed to <font color="blue">risks inherent</font> in the packaging and <font color="blue">distribution</font>     of <font color="blue">pharmaceutical</font>s and other <font color="blue">healthcare products</font> and are <font color="blue">significant</font>ly     <font color="blue">dependent</font>  upon  suppliers  to  provide  safe, <font color="blue">government</font>-approved and     non-counterfeit  products</td>
    </tr>
    <tr>
      <td>Should a product <font color="blue">liability</font> issue arise, the     coverage limits under our insurance programs may not be adequate to protect     us against future claims</td>
    </tr>
    <tr>
      <td>In addition, we may not be able to maintain this     <font color="blue">insurance on</font> acceptable terms in the future and damage to our reputation in     the event of a product <font color="blue">liability</font> issue may have a material adverse effect on     our business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">geographic <font color="blue">concentration</font></font> in the western <font color="blue">United States </font><font color="blue">presents certain</font>     risks that could <font color="blue"><font color="blue">adversely</font> affect</font> us</td>
    </tr>
    <tr>
      <td>Our  stores,  mail order pharmacy <font color="blue">operations</font>, <font color="blue">distribution</font> centers and     corporate  offices  are located in the western United States, with the     majority  of  our stores in California</td>
    </tr>
    <tr>
      <td>Risks prevalent in this region     include, but are not limited to, the <font color="blue">adverse economic effects</font> of <font color="blue">significant</font>     state budget deficits, <font color="blue">legislative</font> or other <font color="blue">government</font>al actions reducing     <font color="blue">prescription</font> <font color="blue">reimbursement</font> payments to us or increasing our <font color="blue">liability</font> with     respect to workers’ compensation, major earthquakes, volatility in energy     supplies  and  costs,  and  shipping  and other transportation-related     <font color="blue"><font color="blue">disruption</font>s</font></td>
    </tr>
    <tr>
      <td>Because of our <font color="blue">geographic <font color="blue">concentration</font></font>, these risks could     result in <font color="blue">significant</font> <font color="blue"><font color="blue">disruption</font>s</font> to our business or increased operating     expenses</td>
    </tr>
  </tbody>
</table>